Want to see AU:ANR full AI Analyst Report?
Anatara Lifesciences Ltd (ANR) Stock Statistics & Valuation Metrics
Total Valuation
Anatara Lifesciences Ltd has a market cap or net worth of AUD 2.53M. The enterprise value is AUD 2.69M.
- Market Cap
- AUD 2.53M
- Enterprise Value
- AUD 2.69M
Share Statistics
Anatara Lifesciences Ltd has 316,310,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 316,310,400
- Owned by Insiders
- 3.64%
- Owned by Institutions
- ―
Financial Efficiency
Anatara Lifesciences Ltd’s return on equity (ROE) is -1.31 and return on invested capital (ROIC) is -131.24%.
- Return on Equity (ROE)
- -1.31
- Return on Assets (ROA)
- -1.14
- Return on Invested Capital (ROIC)
- -131.24%
- Return on Capital Employed (ROCE)
- -1.76
- Revenue Per Employee
- 0
- Profits Per Employee
- -133.32K
- Employee Count
- 7
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Anatara Lifesciences Ltd is -2.35. Anatara Lifesciences Ltd’s PEG ratio is -0.03.
- PE Ratio
- -2.35
- PS Ratio
- 17.97
- PB Ratio
- 3.55
- Price to FCF
- -7.46
- Price to Operating Cash Flow
- -7.45
- PEG Ratio
- -0.03
Income Statement
In the last 12 months, Anatara Lifesciences Ltd had revenue of 0 and earned -933.23K in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- -84
- Operating Income
- -1.25M
- Pretax Income
- -1.25M
- Net Income
- -933.23K
- EBITDA
- -1.25M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -339.24K and capital expenditures -1, giving a free cash flow of -339.24K billion.
- Operating Cash Flow
- -339.24K
- Free Cash Flow
- -339.24K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Anatara Lifesciences Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13.41%
- Earnings Yield
- -36.92%
Stock Price Statistics
- Beta
- 1.05
- 52-Week Price Change
- -23.08%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 27.62
- Average Volume (3m)
- 500.98K
Important Dates
Anatara Lifesciences Ltd upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 23, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Anatara Lifesciences Ltd as a current ratio of 7.58, with Debt / Equity ratio of 0.00%
- Current Ratio
- 7.58
- Quick Ratio
- 7.58
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.38
- Interest Coverage Ratio
- -408.71
Taxes
In the past 12 months, Anatara Lifesciences Ltd has paid -318.40K in taxes.
- Income Tax
- -318.40K
- Effective Tax Rate
- 0.25
Enterprise Valuation
Anatara Lifesciences Ltd EV to EBITDA ratio is -1.64, with an EV/FCF ratio of -6.07.
- EV to Sales
- 14.62
- EV to EBITDA
- -1.64
- EV to Free Cash Flow
- -6.07
- EV to Operating Cash Flow
- -6.07
Balance Sheet
Anatara Lifesciences Ltd has AUD 470.92K in cash and marketable securities with AUD 0.00 in debt, giving a net cash position of AUD 470.92K billion.
- Cash & Marketable Securities
- AUD 470.92K
- Total Debt
- AUD 0.00
- Net Cash
- AUD 470.92K
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is 17.26%, with operating margin of -890.03%, and net profit margin of -662.63%.
- Gross Margin
- 17.26%
- Operating Margin
- -890.03%
- Pretax Margin
- -788.70%
- Net Profit Margin
- -662.63%
- EBITDA Margin
- -889.98%
- EBIT Margin
- -890.03%
Analyst Forecast
The average price target for Anatara Lifesciences Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 64.58%
Scores
- Smart Score
- 5
- AI Score
- 44